David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Herbalife
HLF
$1.3B
| $1.52M | ﹤0.01% |
175,859
-49,372
| -22% | -$367K |
|
2827
Aecom
ACM
$8.38B
| $1.52M | ﹤0.01% |
13,425
-113,669
| -89% | -$11.8M |
|
|
HSII
2828
DELISTED
Heidrick & Struggles
HSII
| $1.51M | ﹤0.01% |
33,074
+9,957
| +43% | +$418K |
|
2829
Taboola.com
TBLA
$1.01B
| $1.51M | ﹤0.01% |
412,967
+390,564
| +1,743% | +$1.27M |
|
2830
PUT
Signet Jewelers
SIG
$3.25B
| $1.51M | ﹤0.01% |
19,000
| – | – |
|
2831
Genie Energy
GNE
$395M
| $1.51M | ﹤0.01% |
56,126
+20,975
| +60% | +$402K |
|
2832
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.2B
| $1.5M | ﹤0.01% |
+20,475
| New | +$1.35M |
|
2833
Seer Inc
SEER
$112M
| $1.5M | ﹤0.01% |
700,125
+15,632
| +2% | +$31.3K |
|
2834
Preferred Bank
PFBC
$1.23B
| $1.49M | ﹤0.01% |
17,258
-11,046
| -39% | -$910K |
|
2835
Impinj
PI
$4.87B
| $1.49M | ﹤0.01% |
13,445
-13,996
| -51% | -$1.39M |
|
2836
Wayfair
W
$14.2B
| $1.49M | ﹤0.01% |
29,194
-97,280
| -77% | -$3.63M |
|
2837
Gaotu Techedu
GOTU
$413M
| $1.49M | ﹤0.01% |
411,458
-115,628
| -22% | -$397K |
|
|
NFBK
2838
DELISTED
Northfield Bancorp
NFBK
| $1.48M | ﹤0.01% |
129,329
-43,692
| -25% | -$485K |
|
2839
SentinelOne
S
$7.03B
| $1.48M | ﹤0.01% |
+81,162
| New | +$1.48M |
|
2840
PUT
Sarepta Therapeutics
SRPT
$2.06B
| $1.48M | ﹤0.01% |
+86,500
| New | +$3.69M |
|
2841
CALL
Aptiv
APTV
$9.61B
| $1.47M | ﹤0.01% |
21,600
-146,900
| -87% | -$9.1M |
|
2842
Banco de Chile
BCH
$21B
| $1.47M | ﹤0.01% |
48,388
+117
| +0.2% | +$3.45K |
|
2843
PUT
Lennar Class A
LEN
$21B
| $1.47M | ﹤0.01% |
13,300
-147,900
| -92% | -$16M |
|
2844
PUT
PagSeguro Digital
PAGS
$2.49B
| $1.47M | ﹤0.01% |
152,400
-18,300
| -11% | -$165K |
|
2845
Alexandria Real Estate Equities
ARE
$9.12B
| $1.47M | ﹤0.01% |
+20,177
| New | +$1.5M |
|
2846
PUT
Ingersoll Rand
IR
$31B
| $1.46M | ﹤0.01% |
17,600
| – | – |
|
2847
Raymond James Financial
RJF
$34B
| $1.46M | ﹤0.01% |
9,534
-47,105
| -83% | -$6.75M |
|
2848
Invesco S&P 500 High Beta ETF
SPHB
$948M
| $1.46M | ﹤0.01% |
14,988
-600
| -4% | -$50.7K |
|
2849
CALL
Mobileye
MBLY
$7.26B
| $1.46M | ﹤0.01% |
81,300
+57,300
| +239% | +$876K |
|
2850
CALL
Vermilion Energy
VET
$1.87B
| $1.46M | ﹤0.01% |
+200,000
| New | +$1.36M |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.